WO2009054434A1 - Npy y5受容体拮抗作用を有するアミン誘導体およびその用途 - Google Patents
Npy y5受容体拮抗作用を有するアミン誘導体およびその用途 Download PDFInfo
- Publication number
- WO2009054434A1 WO2009054434A1 PCT/JP2008/069188 JP2008069188W WO2009054434A1 WO 2009054434 A1 WO2009054434 A1 WO 2009054434A1 JP 2008069188 W JP2008069188 W JP 2008069188W WO 2009054434 A1 WO2009054434 A1 WO 2009054434A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lower alkyl
- npy
- receptor antagonist
- optionally substituted
- amine derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/43—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/72—2-Mercaptobenzothiazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2010003950A MX2010003950A (es) | 2007-10-25 | 2008-10-23 | Derivado de amina que tiene actividad antagonista del receptor y5 de neuropeptido y (npy) y uso del mismo. |
CA2703797A CA2703797A1 (en) | 2007-10-25 | 2008-10-23 | Amine derivative having npy y5 receptor antagonist activity and use thereof |
NZ584816A NZ584816A (en) | 2007-10-25 | 2008-10-23 | Cyclohexyl-substituted sulfonamides having npy y5 receptor antagonist activity and use thereof |
EP08841625.0A EP2221051B1 (en) | 2007-10-25 | 2008-10-23 | Amine derivative having npy y5 receptor antagonist activity and use thereof |
ES08841625.0T ES2445445T3 (es) | 2007-10-25 | 2008-10-23 | Derivado amínico con actividad antagonista del receptor NPY-Y5 y su uso |
AU2008314974A AU2008314974B2 (en) | 2007-10-25 | 2008-10-23 | Amine derivative having NPY Y5 receptor antagonist activity and use thereof |
JP2009513496A JP4375683B2 (ja) | 2007-10-25 | 2008-10-23 | Npyy5受容体拮抗作用を有するアミン誘導体およびその用途 |
BRPI0818216A BRPI0818216A2 (pt) | 2007-10-25 | 2008-10-23 | derivado de amina tendo atividade antagonista do receptor npy y5 e uso do mesmo |
CN2008801133944A CN101835471B (zh) | 2007-10-25 | 2008-10-23 | 具有npy y5受体拮抗活性的胺衍生物 |
ZA2010/01954A ZA201001954B (en) | 2007-10-25 | 2010-03-18 | Amine derivative having npy y5 receptor antagonist activity and use thereof |
US12/767,641 US8299265B2 (en) | 2007-10-25 | 2010-04-26 | Amine derivatives having NPY Y5 receptor antagonistic activity and the uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-277387 | 2007-10-25 | ||
JP2007277387 | 2007-10-25 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/767,641 Continuation-In-Part US8299265B2 (en) | 2007-10-25 | 2010-04-26 | Amine derivatives having NPY Y5 receptor antagonistic activity and the uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009054434A1 true WO2009054434A1 (ja) | 2009-04-30 |
Family
ID=40579536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/069188 WO2009054434A1 (ja) | 2007-10-25 | 2008-10-23 | Npy y5受容体拮抗作用を有するアミン誘導体およびその用途 |
Country Status (18)
Country | Link |
---|---|
US (1) | US8299265B2 (ja) |
EP (1) | EP2221051B1 (ja) |
JP (1) | JP4375683B2 (ja) |
KR (1) | KR20100075949A (ja) |
CN (1) | CN101835471B (ja) |
AR (1) | AR069045A1 (ja) |
AU (1) | AU2008314974B2 (ja) |
BR (1) | BRPI0818216A2 (ja) |
CA (1) | CA2703797A1 (ja) |
CL (1) | CL2008003159A1 (ja) |
ES (1) | ES2445445T3 (ja) |
MX (1) | MX2010003950A (ja) |
NZ (1) | NZ584816A (ja) |
RU (1) | RU2460523C2 (ja) |
SA (1) | SA08290668B1 (ja) |
TW (1) | TWI367752B (ja) |
WO (1) | WO2009054434A1 (ja) |
ZA (1) | ZA201001954B (ja) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010101247A1 (ja) | 2009-03-05 | 2010-09-10 | 塩野義製薬株式会社 | Npy y5受容体拮抗作用を有するシクロヘキサン誘導体 |
WO2011065351A1 (ja) | 2009-11-25 | 2011-06-03 | 塩野義製薬株式会社 | シクロヘキサン誘導体の製造方法 |
WO2011096462A1 (ja) * | 2010-02-04 | 2011-08-11 | 塩野義製薬株式会社 | Npy y5受容体拮抗作用を有するヘテロ環化合物 |
WO2011132075A2 (en) | 2010-04-23 | 2011-10-27 | Shionogi & Company, Ltd. | A hydrate of a cyclohexanamine derivative |
WO2011152442A1 (ja) * | 2010-06-03 | 2011-12-08 | 塩野義製薬株式会社 | 2-クロロ-6-フルオロベンゾオキサゾールの製造方法 |
US8129372B2 (en) | 2008-04-21 | 2012-03-06 | Shionogi & Co., Ltd. | Compounds having NPY Y5 receptor antagonistic activity |
US8227618B2 (en) | 2009-04-23 | 2012-07-24 | Shionogi & Co., Ltd. | Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof |
WO2012147765A1 (ja) * | 2011-04-27 | 2012-11-01 | 塩野義製薬株式会社 | Npy y5受容体拮抗作用を有するベンズイミダゾール誘導体 |
WO2012147764A1 (ja) * | 2011-04-27 | 2012-11-01 | 塩野義製薬株式会社 | Npy y5受容体拮抗作用を有する5員環芳香族複素環誘導体 |
WO2013137371A1 (ja) * | 2012-03-15 | 2013-09-19 | 興和株式会社 | 新規ピリミジン化合物及びそれらを含有する医薬 |
JP2013538801A (ja) * | 2010-08-13 | 2013-10-17 | アボット ゲーエムベーハー ウント カンパニー カーゲー | アミノインダン誘導体、それを含有する医薬組成物および治療におけるそれの使用 |
JP2014101357A (ja) * | 2012-10-26 | 2014-06-05 | Shionogi & Co Ltd | Npyy5受容体拮抗作用を有する医薬組成物 |
US8889674B2 (en) | 2009-03-05 | 2014-11-18 | Shionogi & Co., Ltd. | Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism |
US20150031686A1 (en) * | 2012-03-08 | 2015-01-29 | Institute Of Medicinal Biotechnology, Chinese Academy Of Medical Sciences | Phenyl-oxazolyl derivatives, preparation method thereof, and related application of the phenyl-oxazolyl derivatives as an impdh inhibitor |
JPWO2012169654A1 (ja) * | 2011-06-07 | 2015-02-23 | 独立行政法人科学技術振興機構 | 一酸化炭素(co)による脂肪酸、コレステロールの取り込み阻害 |
JP2015507635A (ja) * | 2011-12-30 | 2015-03-12 | レビバ ファーマシューティカルズ,インコーポレイティド | 組成物、合成およびフェニルシクロアルキルメチルアミン誘導体を使用する方法 |
US9139518B2 (en) | 2006-04-28 | 2015-09-22 | Shionogi & Co., Ltd. | Amine derivative having NPY Y5 receptor antagonistic activity |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012154879A2 (en) | 2011-05-09 | 2012-11-15 | Van Andel Research Institute | Autophagy inhibitors |
CN102775373B (zh) * | 2012-08-10 | 2014-08-20 | 青岛农业大学 | 一种n-取代氨基香豆素类化合物及其制备与应用 |
IL310387A (en) * | 2021-08-09 | 2024-03-01 | Sironax Ltd | Proptosis modulators, their preparation and uses |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996016542A1 (en) | 1994-12-02 | 1996-06-06 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
WO1997020823A2 (en) | 1995-12-01 | 1997-06-12 | Novartis Ag | 2-amino quinazoline derivatives as npy receptor antagonists |
WO1999055667A1 (en) | 1998-04-29 | 1999-11-04 | Ortho-Mcneil Pharmaceutical, Inc. | N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
WO2000064880A1 (en) | 1999-04-22 | 2000-11-02 | Synaptic Pharmaceutical Corporation | Selective npy (y5) antagonists |
WO2000068197A1 (en) | 1999-05-05 | 2000-11-16 | Ortho-Mcneil Pharmaceutical, Inc. | 3a,4,5,9b-TETRAHYDRO-1H-BENZ[e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS |
WO2001002379A1 (en) | 1999-06-30 | 2001-01-11 | Synaptic Pharmaceutical Corporation | Selective npy (y5) antagonists |
WO2001037826A1 (fr) | 1999-11-26 | 2001-05-31 | Shionogi & Co., Ltd. | Antagonistes npyy5 |
WO2005080348A1 (ja) | 2004-02-19 | 2005-09-01 | Banyu Pharmaceutical Co., Ltd. | 新規スルホンアミド誘導体 |
WO2005097738A1 (ja) | 2004-04-06 | 2005-10-20 | Dainippon Sumitomo Pharma Co., Ltd. | 新規スルホンアミド誘導体 |
WO2005121107A1 (en) | 2004-06-09 | 2005-12-22 | F. Hoffmann-La Roche Ag | Pyrazolo pyrimidines |
WO2006001318A1 (ja) | 2004-06-24 | 2006-01-05 | Shionogi & Co., Ltd. | スルホンアミド化合物 |
WO2006014482A1 (en) | 2004-07-08 | 2006-02-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pyrimidine derivatives useful as inhibitors of pkc-theta |
US20060293341A1 (en) | 2005-06-23 | 2006-12-28 | Vrej Jubian | Alkyl sulfonamide derivatives |
WO2007002126A1 (en) | 2005-06-23 | 2007-01-04 | H. Lundbeck A/S | Alkyl sulfonamide derivatives |
US20070060598A1 (en) | 2005-01-13 | 2007-03-15 | Albers Ronald J | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
WO2007125952A1 (ja) * | 2006-04-28 | 2007-11-08 | Shionogi & Co., Ltd. | Npy y5受容体拮抗作用を有するアミン誘導体 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZW4194A1 (en) | 1993-03-29 | 1994-12-21 | Zeneca Ltd | Heterocyclic compounds |
DE19719621A1 (de) * | 1997-05-09 | 1998-11-12 | Hoechst Ag | Sulfonylaminocarbonsäuren |
SE9802206D0 (sv) | 1998-06-22 | 1998-06-22 | Astra Pharma Inc | Novel compounds |
US6583148B1 (en) | 1999-04-08 | 2003-06-24 | Krenitsky Pharmaceuticals, Inc. | Neurotrophic substituted pyrimidines |
US6124331A (en) * | 1999-06-30 | 2000-09-26 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
NZ516782A (en) * | 1999-07-28 | 2004-12-24 | Ortho Mcneil Pharm Inc | Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
DE10027514A1 (de) * | 2000-06-06 | 2002-01-03 | Basf Ag | Liganden von Integrinrezeptoren |
US7491748B2 (en) * | 2001-08-09 | 2009-02-17 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
EP1679309A4 (en) * | 2003-10-24 | 2007-03-28 | Ono Pharmaceutical Co | ANTISTRESS MEDICAMENT AND ITS MEDICAL USE |
JPWO2006014024A1 (ja) | 2004-08-06 | 2008-05-01 | 小野薬品工業株式会社 | 精神神経系疾患治療剤 |
JP2006124387A (ja) | 2004-09-30 | 2006-05-18 | Taisho Pharmaceut Co Ltd | 新規なキノリン、テトラヒドロキナゾリン、及びピリミジン誘導体と、これらを使用することに関連した治療方法 |
TW200800979A (en) | 2006-03-07 | 2008-01-01 | Lundbeck & Co As H | Halogenated sulfonamide derivatives |
WO2008026563A1 (fr) * | 2006-08-30 | 2008-03-06 | Shionogi & Co., Ltd. | Dérivé d'hydrazine amide |
WO2008026564A1 (fr) * | 2006-08-30 | 2008-03-06 | Shionogi & Co., Ltd. | Dérivés d'urée |
WO2008134228A1 (en) | 2007-04-30 | 2008-11-06 | H. Lundbeck A/S | Benzoxazole compounds |
-
2008
- 2008-10-22 SA SA8290668A patent/SA08290668B1/ar unknown
- 2008-10-23 NZ NZ584816A patent/NZ584816A/en not_active IP Right Cessation
- 2008-10-23 EP EP08841625.0A patent/EP2221051B1/en active Active
- 2008-10-23 AU AU2008314974A patent/AU2008314974B2/en not_active Ceased
- 2008-10-23 RU RU2010120808/15A patent/RU2460523C2/ru not_active IP Right Cessation
- 2008-10-23 ES ES08841625.0T patent/ES2445445T3/es active Active
- 2008-10-23 CA CA2703797A patent/CA2703797A1/en not_active Abandoned
- 2008-10-23 CN CN2008801133944A patent/CN101835471B/zh not_active Expired - Fee Related
- 2008-10-23 BR BRPI0818216A patent/BRPI0818216A2/pt not_active IP Right Cessation
- 2008-10-23 MX MX2010003950A patent/MX2010003950A/es active IP Right Grant
- 2008-10-23 JP JP2009513496A patent/JP4375683B2/ja not_active Expired - Fee Related
- 2008-10-23 KR KR1020107008907A patent/KR20100075949A/ko active IP Right Grant
- 2008-10-23 WO PCT/JP2008/069188 patent/WO2009054434A1/ja active Application Filing
- 2008-10-24 AR ARP080104670A patent/AR069045A1/es unknown
- 2008-10-24 CL CL2008003159A patent/CL2008003159A1/es unknown
- 2008-10-24 TW TW097140777A patent/TWI367752B/zh not_active IP Right Cessation
-
2010
- 2010-03-18 ZA ZA2010/01954A patent/ZA201001954B/en unknown
- 2010-04-26 US US12/767,641 patent/US8299265B2/en not_active Expired - Fee Related
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996016542A1 (en) | 1994-12-02 | 1996-06-06 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
WO1997020823A2 (en) | 1995-12-01 | 1997-06-12 | Novartis Ag | 2-amino quinazoline derivatives as npy receptor antagonists |
WO1999055667A1 (en) | 1998-04-29 | 1999-11-04 | Ortho-Mcneil Pharmaceutical, Inc. | N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
JP2004503462A (ja) * | 1998-04-29 | 2004-02-05 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 肥満症及び他の障害の処置において有用な神経ペプチドyy5レセプターのためのリガンドとしてのn−置換アミノテトラリン |
JP2002543067A (ja) * | 1999-04-22 | 2002-12-17 | シナプティック・ファーマスーティカル・コーポレーション | 選択的なnpy(y5)のアンタゴニスト |
WO2000064880A1 (en) | 1999-04-22 | 2000-11-02 | Synaptic Pharmaceutical Corporation | Selective npy (y5) antagonists |
WO2000068197A1 (en) | 1999-05-05 | 2000-11-16 | Ortho-Mcneil Pharmaceutical, Inc. | 3a,4,5,9b-TETRAHYDRO-1H-BENZ[e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS |
JP2003503486A (ja) * | 1999-06-30 | 2003-01-28 | シナプティック・ファーマスーティカル・コーポレーション | 選択的npy(y5)アンタゴニスト |
WO2001002379A1 (en) | 1999-06-30 | 2001-01-11 | Synaptic Pharmaceutical Corporation | Selective npy (y5) antagonists |
WO2001037826A1 (fr) | 1999-11-26 | 2001-05-31 | Shionogi & Co., Ltd. | Antagonistes npyy5 |
WO2005080348A1 (ja) | 2004-02-19 | 2005-09-01 | Banyu Pharmaceutical Co., Ltd. | 新規スルホンアミド誘導体 |
WO2005097738A1 (ja) | 2004-04-06 | 2005-10-20 | Dainippon Sumitomo Pharma Co., Ltd. | 新規スルホンアミド誘導体 |
WO2005121107A1 (en) | 2004-06-09 | 2005-12-22 | F. Hoffmann-La Roche Ag | Pyrazolo pyrimidines |
WO2006001318A1 (ja) | 2004-06-24 | 2006-01-05 | Shionogi & Co., Ltd. | スルホンアミド化合物 |
WO2006014482A1 (en) | 2004-07-08 | 2006-02-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pyrimidine derivatives useful as inhibitors of pkc-theta |
US20070060598A1 (en) | 2005-01-13 | 2007-03-15 | Albers Ronald J | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
US20060293341A1 (en) | 2005-06-23 | 2006-12-28 | Vrej Jubian | Alkyl sulfonamide derivatives |
WO2007002126A1 (en) | 2005-06-23 | 2007-01-04 | H. Lundbeck A/S | Alkyl sulfonamide derivatives |
WO2007125952A1 (ja) * | 2006-04-28 | 2007-11-08 | Shionogi & Co., Ltd. | Npy y5受容体拮抗作用を有するアミン誘導体 |
Non-Patent Citations (5)
Title |
---|
DESWAL, SUMIT ET AL.: "A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 42, no. 4, 2 November 2006 (2006-11-02), pages 463 - 470 * |
INUI, A. ET AL., ENDOCRINOLOGY, vol. 131, 1992, pages 2090 - 2096 |
PEPTIDES, vol. 18, 1997, pages 445 |
See also references of EP2221051A4 |
TAKEBE ET AL., MOL. CELL. BIOL., vol. 8, pages 466 - 472 |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9150507B2 (en) | 2006-04-28 | 2015-10-06 | Shionogi & Co., Ltd. | Amine derivative having NPY Y5 receptor antagonistic activity |
US9139518B2 (en) | 2006-04-28 | 2015-09-22 | Shionogi & Co., Ltd. | Amine derivative having NPY Y5 receptor antagonistic activity |
US8129372B2 (en) | 2008-04-21 | 2012-03-06 | Shionogi & Co., Ltd. | Compounds having NPY Y5 receptor antagonistic activity |
US8299066B2 (en) | 2008-04-21 | 2012-10-30 | Shionogi & Co., Ltd. | Compounds having NPY Y5 receptor antagonistic activity |
WO2010101247A1 (ja) | 2009-03-05 | 2010-09-10 | 塩野義製薬株式会社 | Npy y5受容体拮抗作用を有するシクロヘキサン誘導体 |
US8889674B2 (en) | 2009-03-05 | 2014-11-18 | Shionogi & Co., Ltd. | Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism |
US8227618B2 (en) | 2009-04-23 | 2012-07-24 | Shionogi & Co., Ltd. | Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof |
WO2011065351A1 (ja) | 2009-11-25 | 2011-06-03 | 塩野義製薬株式会社 | シクロヘキサン誘導体の製造方法 |
WO2011096462A1 (ja) * | 2010-02-04 | 2011-08-11 | 塩野義製薬株式会社 | Npy y5受容体拮抗作用を有するヘテロ環化合物 |
WO2011132075A2 (en) | 2010-04-23 | 2011-10-27 | Shionogi & Company, Ltd. | A hydrate of a cyclohexanamine derivative |
WO2011132075A3 (en) * | 2010-04-23 | 2012-06-07 | Shionogi & Company, Ltd. | A hydrate of a cyclohexanamine derivative |
WO2011152442A1 (ja) * | 2010-06-03 | 2011-12-08 | 塩野義製薬株式会社 | 2-クロロ-6-フルオロベンゾオキサゾールの製造方法 |
JP2013538801A (ja) * | 2010-08-13 | 2013-10-17 | アボット ゲーエムベーハー ウント カンパニー カーゲー | アミノインダン誘導体、それを含有する医薬組成物および治療におけるそれの使用 |
JP5557302B2 (ja) * | 2011-04-27 | 2014-07-23 | 塩野義製薬株式会社 | Npyy5受容体拮抗作用を有する5員環芳香族複素環誘導体 |
US8916594B2 (en) | 2011-04-27 | 2014-12-23 | Shionogi & Co., Ltd. | 5-membered ring heteroaromatic derivatives having NPY Y5 receptor antagonistic activity |
WO2012147764A1 (ja) * | 2011-04-27 | 2012-11-01 | 塩野義製薬株式会社 | Npy y5受容体拮抗作用を有する5員環芳香族複素環誘導体 |
WO2012147765A1 (ja) * | 2011-04-27 | 2012-11-01 | 塩野義製薬株式会社 | Npy y5受容体拮抗作用を有するベンズイミダゾール誘導体 |
KR101893237B1 (ko) * | 2011-04-27 | 2018-08-29 | 시오노기세야쿠 가부시키가이샤 | Npy y5 수용체 길항 작용을 갖는 5원환 방향족 복소환 유도체 |
JPWO2012169654A1 (ja) * | 2011-06-07 | 2015-02-23 | 独立行政法人科学技術振興機構 | 一酸化炭素(co)による脂肪酸、コレステロールの取り込み阻害 |
JP2015507635A (ja) * | 2011-12-30 | 2015-03-12 | レビバ ファーマシューティカルズ,インコーポレイティド | 組成物、合成およびフェニルシクロアルキルメチルアミン誘導体を使用する方法 |
US20150031686A1 (en) * | 2012-03-08 | 2015-01-29 | Institute Of Medicinal Biotechnology, Chinese Academy Of Medical Sciences | Phenyl-oxazolyl derivatives, preparation method thereof, and related application of the phenyl-oxazolyl derivatives as an impdh inhibitor |
WO2013137371A1 (ja) * | 2012-03-15 | 2013-09-19 | 興和株式会社 | 新規ピリミジン化合物及びそれらを含有する医薬 |
JPWO2013137371A1 (ja) * | 2012-03-15 | 2015-08-03 | 興和株式会社 | 新規ピリミジン化合物及びそれらを含有する医薬 |
JP2014101357A (ja) * | 2012-10-26 | 2014-06-05 | Shionogi & Co Ltd | Npyy5受容体拮抗作用を有する医薬組成物 |
Also Published As
Publication number | Publication date |
---|---|
BRPI0818216A2 (pt) | 2015-09-29 |
RU2010120808A (ru) | 2011-11-27 |
AU2008314974A1 (en) | 2009-04-30 |
MX2010003950A (es) | 2010-04-30 |
NZ584816A (en) | 2012-04-27 |
ZA201001954B (en) | 2011-05-25 |
CL2008003159A1 (es) | 2009-11-13 |
RU2460523C2 (ru) | 2012-09-10 |
AR069045A1 (es) | 2009-12-23 |
EP2221051A4 (en) | 2011-04-27 |
AU2008314974B2 (en) | 2013-08-22 |
JP4375683B2 (ja) | 2009-12-02 |
US8299265B2 (en) | 2012-10-30 |
EP2221051A1 (en) | 2010-08-25 |
JPWO2009054434A1 (ja) | 2011-03-03 |
TWI367752B (en) | 2012-07-11 |
US20100273842A1 (en) | 2010-10-28 |
SA08290668B1 (ar) | 2012-02-12 |
ES2445445T3 (es) | 2014-03-03 |
KR20100075949A (ko) | 2010-07-05 |
CN101835471A (zh) | 2010-09-15 |
CN101835471B (zh) | 2012-10-10 |
TW200924740A (en) | 2009-06-16 |
EP2221051B1 (en) | 2013-12-11 |
CA2703797A1 (en) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009054434A1 (ja) | Npy y5受容体拮抗作用を有するアミン誘導体およびその用途 | |
NO20084983L (no) | Aminderivat med NPY Y5 reseptorantagonistaktivitet | |
EP2520567A3 (en) | Nitrogen-containing heterocycle derivatives substituted with cyclic group | |
BR0015843A (pt) | Antagonista de y5 para npy | |
RS51943B (en) | PIPERIDINSKI GPCR AGONIST | |
MX2010002266A (es) | Derivados de pirazol sustituidos. | |
NO20050164L (no) | Nye quinuklidin-amid-derivater | |
RS52168B (en) | PIPERIDINSKI GPCR AGONIST | |
TW200730501A (en) | Heterocyclic derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase I | |
NO20050217L (no) | Nye quinuklidin-karbamat-derivater samt medisinske sammensetninger inneholdende slike | |
ATE435862T1 (de) | Azabicycloalkanverbindungen als muscarinrezeptor antagonisten | |
EP1700856A4 (en) | thiazole | |
EP1760073A4 (en) | SULPHONAMIDE COMPOUND | |
TW200716576A (en) | Heterocyclic derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | |
EP1798227A4 (en) | SEROTONIN 5-HT3 RECEPTOR AGONIST | |
WO2009057784A1 (ja) | 複素環化合物 | |
ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren | |
RS51369B (en) | ANTAGONISTI RECEPTORA PROGESTERONA | |
JO2644B1 (en) | Derivatives of N- (amino-aryl mixture) -H1- indole-2-carboxamide Synthesis and therapeutic use | |
WO2008007113A3 (en) | Pharmaceutical combinations | |
BRPI0513777A (pt) | composto ou um sal do mesmo, composição farmacêutica, e, uso de um composto ou de um sal do mesmo | |
BRPI0619894B8 (pt) | composto de amina e composição farmacêutica | |
BR112015015275A8 (pt) | composto heterocíclico substituído por halogênio, antagonista do receptor de lpa, composição farmacêutica e uso | |
MX2010008360A (es) | Derivados de oxazepinopirimidona heteroarilamida sustituidos. | |
TW200745104A (en) | Multikinase inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880113394.4 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2009513496 Country of ref document: JP Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08841625 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2010/003950 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008314974 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 584816 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2325/CHENP/2010 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 20107008907 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2703797 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2008314974 Country of ref document: AU Date of ref document: 20081023 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010120808 Country of ref document: RU Ref document number: 2008841625 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0818216 Country of ref document: BR Kind code of ref document: A2 Effective date: 20100422 |